Loading clinical trials...
Loading clinical trials...
A Randomized, Blinded and Placebo-Control Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above
Conditions
Interventions
ABO1105
Placebo
Locations
1
China
Baise Center For Disease Control & Prevention
Baise City, Baise, China
Start Date
September 15, 2025
Primary Completion Date
January 7, 2026
Completion Date
October 15, 2027
Last Updated
December 17, 2025
NCT07220109
NCT07092865
NCT04959734
NCT07239583
NCT05045612
NCT06984094
Lead Sponsor
Suzhou Abogen Biosciences Co., Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions